Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (brand name Mounjaro) and chronic weight management (brand name Zepbound)
The bumps are usually red or flesh-colored and typically occur on the upper arms, thighs and buttocks, but they can also appear on the face
As youll see below, each GLP-1 approach has its own set of benefits and drawbacks
The acronym that names this gene provides instructions for methylenetetrahydrofolate reductase, the enzyme used to convert folic acid (vitamin B9) into folates active form, methyl-folate (5MTHF)
Overall, these findings indicate that targeting both GIPR and GLP-1R in the CNS with peptideantibody conjugates, enabling GIPR blockade together with GLP-1R agonism, enhances weight loss
However, compounded medications are not FDA-approved, so choosing a trusted, reputable provider is critical to making sure you see the benefits you want without any additional risks